Brain metastases (BM) in pancreatic ductal adenocarcinoma (PDAC): Clinical and molecular characteristics.

被引：0
|
作者：
Jordan, Emmet
Kaley, Thomas Joseph
Capanu, Marinela
Estrella, Hayley
Leach, Steven D.
Basturk, Olca
Klimstra, David S.
Allen, Peter J.
Berger, Michael F.
Yu, Kenneth H.
Lowery, Maeve Aine
O'Reilly, Eileen Mary
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, David M Rubenstein Ctr Pancreat Canc Res, 1275 York Ave, New York, NY 10021 USA
[3] Weill Cornell Med Coll, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15728
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15728
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma
    Yousef, Mahmoud
    Hurd, Mark W.
    Yousef, Abdelrahman
    Ludmir, Ethan B.
    Pillai, Ashwathy B.
    Peterson, Jennifer
    Koay, Eugene J.
    Albarouki, Sali
    Tzeng, Ching-Wei
    Snyder, Rebecca
    Katz, Matthew H. G.
    Wang, Huamin
    Overman, Michael J.
    Maitra, Anirban
    Pant, Shubham
    Smaglo, Brandon G.
    Wolff, Robert A.
    Yao, James
    Shen, John P.
    Zhao, Dan
    ONCOLOGIST, 2024, 30 (01):
  • [2] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Zoratti, Mario
    Szabo, Ildiko
    Biasutto, Lucia
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
  • [3] Skeletal metastases in advanced pancreatic ductal adenocarcinoma (PDAC): A retrospective analysis.
    Puri, Akshjot
    Chang, John
    Dragovich, Tomislav
    Lucente, Patricia
    Kundranda, Madappa N.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [4] Clinicopathologic Characteristics and Biologic Behavior of Concurrent Pancreatic Ductal Adenocarcinoma (PDAC)
    Lew, M.
    Morales-Oyarvide, V.
    Liao, X.
    Ogino, S.
    Chen, J-H
    Pitman, M. B.
    Mino-Kenudson, M.
    MODERN PATHOLOGY, 2012, 25 : 446A - 446A
  • [5] Clinicopathologic Characteristics and Biologic Behavior of Concurrent Pancreatic Ductal Adenocarcinoma (PDAC)
    Lew, M.
    Morales-Oyarvide, V.
    Liao, X.
    Ogino, S.
    Chen, J-H
    Pitman, M. B.
    Mino-Kenudson, M.
    LABORATORY INVESTIGATION, 2012, 92 : 446A - 446A
  • [6] Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Norton, Carter
    Smith, Jarrod
    Rubnitz, Zach
    Tan, Grace H.
    Nevala-Plagemann, Christopher Duane
    Soares, Heloisa P.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 619 - 619
  • [7] Clinical impact of visceral thrombosis (VT) in pancreatic ductal adenocarcinoma (PDAC).
    Hicks, Angel Mier
    Raj, Micheal
    Do, Richard Kinh Gian
    Yu, Kenneth H.
    Lowery, Maeve Aine
    Varghese, Anna M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] Prognosis and clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma.
    Yousef, Mahmoud M. G.
    Yousef, Abdelrahman M. G.
    Hurd, Mark W.
    Ludmir, Ethan B.
    Koay, Eugene Jon
    Snyder, Rebecca A.
    Wang, Huamin
    Tzeng, Ching-Wei D.
    Maitra, Anirban
    Pant, Shubham
    Yao, James C.
    Shen, John Paul Y. C.
    Zhao, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 635 - 635
  • [9] Pancreatic ductal adenocarcinoma (PDAC): clinical progress in the last five years
    Mosalem, Osama M.
    Abdelhakeem, Ahmed
    Abdel-Razeq, Nayef H.
    Babiker, Hani
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2025, 34 (03) : 149 - 160
  • [10] Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
    Le, Kai
    Wang, Jia
    Zhang, Tao
    Guo, Yifan
    Chang, Hong
    Wang, Siyuan
    Zhu, Bin
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (04): : 422 - 427
12345